ConductScience.org, home

Paper23933259

Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.

Os A and 8 others. Cell Rep, 2013. Cited by 88 papers, by iCite.

Cite this record

ConductScience Library. Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells. Papers, record 23933259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23933259

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.
PubMed
Journal
Cell Rep
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
2.07
iCite
Revised in PubMed
2021-01-02
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Os AAudun
2Bürgler SSimone
3Ribes APAnna Parente
4Funderud AAne
5Wang DDong
6Thompson KMKeith M
7Tjønnfjord GEGeir E
8Bogen BBjarne
9Munthe LALudvig A

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, Lymphocytic, Chronic, B-CellMajor topic
Th1 CellsMajor topic
Animals
Antigen-Presenting Cells
Cell Growth Processes
Humans
Lymphocyte Activation
Mice
Mice, Inbred NOD
Mice, SCID
Transcriptome
Tumor Microenvironment

Source PubMed

Download CSV of topics

Cited by68

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
42959570T cell-driven venetoclax resistance in chronic lymphocytic leukemia: in vivo preclinical activity of opaganib.Front Immunol2026https://conductscience.org/library/papers/42959570PubMed
42769825Non-Malignant T Cells as Determinants of Immunotherapeutic Response in Chronic Lymphocytic Leukemia: Towards Personalized Strategies.Oncol Res2026https://conductscience.org/library/papers/42769825PubMed
41741475Idiotype-specific CD4+ T cells chronically stimulate autoreactive B cells to develop into B lymphomas in mice.Nat Commun2026https://conductscience.org/library/papers/41741475PubMed
40906805PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapy.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40906805PubMed
40571973Single-cell insights into the role of T cells in B-cell malignancies.FEBS Lett2025https://conductscience.org/library/papers/40571973PubMed
40313718Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemia.Front Cell Dev Biol2025https://conductscience.org/library/papers/40313718PubMed
39941719Normal Residual Lymphoid Cell Populations in Blood as Surrogate Biomarker of the Leukemia Cell Kinetics in CLL BinetA/Rai 0.Cancers (Basel)2025https://conductscience.org/library/papers/39941719PubMed
39474602CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity.Mol Ther Oncol2024https://conductscience.org/library/papers/39474602PubMed
38928031Optimization of In Vitro Th17 Polarization for Adoptive Cell Therapy in Chronic Lymphocytic Leukemia.Int J Mol Sci2024https://conductscience.org/library/papers/38928031PubMed
38877102
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs.
Leukemia2024https://conductscience.org/library/papers/38877102PubMed
38606091CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression.Front Oncol2024https://conductscience.org/library/papers/38606091PubMed
37190234Extracellular Vesicles in Chronic Lymphocytic Leukemia: Tumor Microenvironment Messengers as a Basis for New Targeted Therapies?Cancers (Basel)2023https://conductscience.org/library/papers/37190234PubMed
37100883Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation.Leukemia2023https://conductscience.org/library/papers/37100883PubMed
37064123NF-kB and the CLL microenvironment.Front Oncol2023https://conductscience.org/library/papers/37064123PubMed
36574293The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?Blood Adv2023https://conductscience.org/library/papers/36574293PubMed
36266281Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape.Nat Commun2022https://conductscience.org/library/papers/36266281PubMed
35883619CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints.Cells2022https://conductscience.org/library/papers/35883619PubMed
35804862In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug Testing.Cancers (Basel)2022https://conductscience.org/library/papers/35804862PubMed
35655388T-helper cell regulation of CD45 phosphatase activity by galectin-1 and CD43 governs chronic lymphocytic leukaemia proliferation.Br J Haematol2022https://conductscience.org/library/papers/35655388PubMed
35309250B-cell receptor dependent phagocytosis and presentation of particulate antigen by chronic lymphocytic leukemia cells.Explor Target Antitumor Ther2022https://conductscience.org/library/papers/35309250PubMed

See all 68 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD40LG959PubTator's text mininghttps://conductscience.org/library/genes/959

Source NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GEOGSE48268

Source GEO

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23933259

GET https://conductscience.org/api/papers/v1/23933259/cited_by?page=2